Patents by Inventor Manuel Allen Revez Ferreira

Manuel Allen Revez Ferreira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors
    Publication number: 20210238599
    Abstract: The present disclosure provides methods of treating patients having an ophthalmic condition, methods of identifying subjects having an increased risk of developing an ophthalmic condition, methods of detecting human Son of Sevenless 2 (SOS2) variant nucleic acid molecules and variant polypeptides.
    Type: Application
    Filed: February 3, 2021
    Publication date: August 5, 2021
    Inventors: Kavita Praveen, Giovanni Coppola, Manuel Allen Revez Ferreira, Lauren Gurski, Goncalo Abecasis, Aris Baras
  • Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
    Publication number: 20210046157
    Abstract: Methods of treating patients having inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) are provided herein.
    Type: Application
    Filed: August 11, 2020
    Publication date: February 18, 2021
    Inventors: Julie Horowitz, Aris Baras, Manuel Allen Revez Ferreira
  • Synaptojanin 2 (SYNJ2) Variants And Uses Thereof
    Publication number: 20200370119
    Abstract: The present disclosure provides methods of treating patients having hearing loss, methods of identifying subjects having an increased risk of developing hearing loss, methods of detecting human Synaptojanin-2 (SYNJ2) variant nucleic acid molecules and variant polypeptides, and SYNJ2 variant nucleic acid molecules and variant polypeptides.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 26, 2020
    Inventors: Kavita Praveen, Giovanni Coppola, Manuel Allen Revez Ferreira, Lauren Gurski, Aris Baras, Meghan Drummond Samuelson, Goncalo Abecasis